Published February 28, 2019
| Version v1
Journal article
Open
Sequencing of ACVR1/ALK2 in patient derived DIPG cell lines
Description
Report outlining how genomic DNA was extracted from patient derived diffuse intrinsic pontine glioma cell lines*, PCR was used to amplify commonly mutated exons of ACVR1, and the regions Sanger sequenced.
* Lines HSJD-GBM-002, SU-DIPG-IV, HSJD-DIPG-006, HSJD-DIPG-007, HSJD-DIPG-011, SU-DIPG-XXI
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
20190218_sequencing ACVR1 mutant exons in patient derived DIPG cells.pdf
Files
(2.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:71996f3e80f7fbcdee0b7556adf8c8d9
|
500.1 kB | Preview Download |
|
md5:3cab782364be745afa83e50f0bb7a982
|
2.2 MB | Preview Download |